Foundation for Angelman Syndrome Therapeutics

Foundation for Angelman Syndrome Therapeutics

Downers Grove, IL 60515
Tax ID26-3160079

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$Currency USD
20

Daffy covers the bank/ACH transaction fees so 100% of your donation goes to your favorite charities. Daffy also waives fees for your first credit or debit card donation up to $1,000. After that, there is a 2.9% surcharge to cover fees charged by payment processors.

Do you work for Foundation for Angelman Syndrome Therapeutics? Learn more here.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.

More about this organization

Mission

Fast is run by an all-volunteer board of Angelman syndrome (AS) parents and professionals dedicated to finding a cure for AS and related disorders through the funding of an aggressive research agenda. The foundation is committed to assisting individuals living with Angelman syndrome to realize their full potential and quality of life. Our goal is to bring practical treatment into current medical practice as quickly as possible. It is our hope that grants we fund will lead to additional research support from government agencies, other funding sources and organizations around the globe. Fast is served by two boards: the board of directors and the scientific advisory board. Together, we are working hard to bring practical treatment into current medical practice as quickly as possible.

About

Fast's primary goal is to advance research leading to a cure for AS.

Revenue

$5,274,393

Expenses

$2,948,068